Athersys to Host First Quarter Financial Results Call

Rhea-AI Summary

Athersys, Inc. (Nasdaq: ATHX) is set to release its first quarter 2021 financial results on May 6, 2021, at 4:00 PM ET, followed by a conference call at 4:30 PM ET. The call will be hosted by management and will include a review of the financial results. Shareholders can register for the call using the provided links for both webcast and phone access. A replay of the event will be available on Athersys' website approximately two hours after the call concludes. Athersys focuses on developing its MultiStem® cell therapy for various critical care indications.

Positive

• Scheduled release of Q1 2021 financial results indicating transparency and accountability.
• Scheduled conference call to discuss financial results suggests proactive investor engagement.

Negative

• None.

Athersys, Inc. (Nasdaq: ATHX) will release its first quarter 2021 financial results at approximately 4:00 PM Eastern Time on Thursday, May 6, 2021, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.

Members of the management team will host the call as follows:

Date	May 6, 2021
Time	4:30 p.m. (Eastern Time)
Live webcast registration	Webcast link
Phone registration	Call registration link

We encourage shareholders to listen using the webcast link above. If you would like to dial in using the phone to ask a question, please register for the conference call ahead of time using the call registration link above. Once registered, you will receive an email containing the toll-free number, a direct entry passcode and a registrant ID.

A replay of the event will be available on the webcast link at www.athersys.com under the investors' section approximately two hours after the call has ended. Shareholders may also call in for on-demand listening approximately three hours after the completion of the call until 11:59 PM Eastern Time on May 12, 2021, by dialing (800) 585-8367 or (416) 621-4642 and entering the conference code 4548767.

About Athersys

Athersys is a biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem^® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular and other critical care indications and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization. More information is available at www.athersys.com. Follow Athersys on Twitter at www.twitter.com/athersys.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210413005208/en/

FAQ

When will Athersys release its Q1 2021 financial results?

Athersys will release its Q1 2021 financial results on May 6, 2021, at 4:00 PM ET.

What time is the Athersys Q1 2021 conference call?

The Athersys Q1 2021 conference call is at 4:30 PM ET on May 6, 2021.

How can I access the Athersys Q1 2021 conference call?

You can access the Athersys Q1 2021 conference call via the provided webcast link or by registering for phone access.

Will the Athersys conference call be available for replay?

Yes, a replay of the Athersys conference call will be available on their website approximately two hours after the call.

What is the focus of Athersys' MultiStem® cell therapy?

Athersys' MultiStem® cell therapy is designed for critical care indications, including neurological, inflammatory, immune, and cardiovascular diseases.